Biomarkers of Sepsis

Early Biomarkers of Sepsis

Biomarkers in sepsis are critical laboratory parameters used for the early identification of systemic infection, assessment of disease severity, and continuous monitoring of the patient's response to therapeutic interventions.
A combination of biochemical markers and tissue oxygenation parameters must be routinely utilized, as isolated clinical parameters can be easily confounded by external factors such as pain, fever, and medications.
During the early phases of septic shock, a dysregulated host response to infection leads to severe cardiovascular and non-cardiovascular organ dysfunction.
This dysregulation manifests as a profound imbalance between oxygen delivery and cellular oxygen consumption, which directly drives the alterations seen in early sepsis biomarkers.

Lactate serves as a primary, high-yield marker of decreased tissue perfusion and anaerobic metabolism in the setting of septic shock.
Pathophysiologically, it is formed by the reduction of pyruvic acid, and its levels become rapidly elevated during states of circulatory compromise and tissue hypoxia.
Elevated blood lactate (> 2 mmol/L) holds a pivotal role in the diagnosis of septic shock and has been included as an essential diagnostic criterion in standard septic shock definitions.
In clinical management, lactate acts as a highly sensitive surrogate marker for detecting "cryptic shock," identifying children who have profound cellular perfusion deficits despite maintaining a normal blood pressure.
Lactate kinetics, particularly the clearance of lactate over time, are more strongly correlated with clinical outcomes than a single static measurement.
Higher lactate levels at admission and reduced clearance rates are significantly associated with increased mortality; specifically, values > 5 mmol/L within the first 0-3 hours of PICU admission yield a 6.7 times higher odds of death compared to lower values.

Both C-reactive protein (CRP) and procalcitonin (PCT) are widely recognized as primary bacterial sepsis biomarkers.
They are employed in early clinical evaluations to confirm the presence of a bacterial infection and to help differentiate it from other non-infectious causes of systemic inflammation.
Procalcitonin, specifically, has been shown to be a highly useful marker of infection in critically ill pediatric patients, including those presenting with multiorgan involvement.
CRP is utilized as a vital acute-phase reactant in risk-stratification models; for example, a CRP level > 60 mg/L is assigned significant prognostic weight when identifying high-risk patients in conditions like febrile neutropenia.
Elevated levels of these inflammatory markers, especially when seen alongside a neutrophil-predominant leukocyte count > 20,000/mm³, provide strong evidence of an underlying medical catastrophe or severe sepsis.

While technically a physiologic parameter, ScvO2 functions as a critical bedside biomarker for global tissue oxygenation and perfusion.
It is used as a reliable surrogate for mixed venous oxygen saturation (SvO2), with normal physiological values being > 70%.
ScvO2 provides a direct indication of the body's oxygen extraction ratio; low levels imply severe tissue hypoxia and an ongoing imbalance between oxygen delivery and systemic consumption.
In the acute management of septic shock, ScvO2 is utilized alongside blood lactate to guide early fluid resuscitation and the titration of inotropic therapy.

Arterial blood gas analysis provides essential early biochemical markers in the form of pH and base deficit.
The calculation of the base deficit aids in the direct quantification of tissue hypoperfusion, as the severity of the metabolic acidosis strongly correlates with the severity of cellular hypoperfusion.

The integration of these biomarkers is central to Early Goal-Directed Therapy (EGDT) in pediatric septic shock, which uses these laboratory parameters to titrate therapeutic endpoints.

Biomarker / Parameter	Pathophysiological Origin	Role in Sepsis Management	Target Endpoints in Therapy
Blood Lactate	Anaerobic metabolism and pyruvic acid reduction due to inadequate tissue perfusion.	Acts as a diagnostic marker for cryptic shock; used for continuous monitoring of resuscitation response.	Normalization of blood lactate levels.
Procalcitonin (PCT)	Upregulated systemically in response to bacterial endotoxins and severe inflammation.	Facilitates early identification of bacterial sepsis and guides antimicrobial initiation.	Decreasing trend correlates with infection resolution.
C-Reactive Protein (CRP)	Acute-phase reactant released during systemic inflammation.	Assesses the severity of inflammation and assists in risk stratification.	Reduction indicates the resolution of the inflammatory state.
ScvO2	Reflects the balance between systemic oxygen delivery and oxygen consumption.	Identifies tissue hypoxia; guides fluid, inotrope, and vasopressor titration.	Maintenance of ScvO2 ≥ 70%.
Base Deficit	Accumulation of acidic byproducts (e.g., lactic acid) due to cellular hypoperfusion.	Quantifies the exact severity of tissue hypoperfusion and ongoing metabolic acidosis.	Resolution of metabolic acidosis.

The multimodal monitoring of these biomarkers allows clinicians to dynamically titrate therapeutic interventions.
The normalization of these biomarker parameters (such as achieving a normal lactate and ScvO2 ≥ 70%), alongside the normalization of clinical signs (e.g., capillary refill < 2 seconds, normal heart rate), definitively indicates the successful resolution of shock.